or Try an Advanced Search...

    Chronic Condition Stocks List

    Symbol Grade Name % Change
    TTNP F Titan Pharmaceuticals, Inc. -3.01
    EPRX F Eupraxia Pharmaceuticals Inc. 0.60
    OPCH F Option Care Health, Inc. -0.78
    PTPI F Petros Pharmaceuticals, Inc. -2.15
    BTCY F Biotricity, Inc. -2.52
    PXMD F PaxMedica, Inc. 24.94
    TCMD F Tactile Systems Technology, Inc. -1.22
    EHAB D Enhabit, Inc. -1.37
    HUMA D Humacyte, Inc. -7.05
    AZN C Astrazeneca PLC 0.70
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Medical Care Medical Care Facilities Medical Devices
    Related Stock Lists: Disease Medicine Arthritis Chronic Pain Diabetes Disorders Drug Delivery Technology Health Care Health Sciences Hypertension Parkinson's Disease Respiratory Diseases Schizophrenia Acid Alzheimer's Disease Anemia Angina Antibodies Antipsychotic Asthma

    Related ETFs - A few ETFs which own one or more of the above listed Chronic Condition stocks.

    Symbol Grade Name Weight
    MEDX B Horizon Kinetics Medical ETF 5.73
    PPH B Market Vectors Pharmaceutical ETF 4.91
    FLUD C Franklin Liberty Ultra Short Bond ETF 4.07
    IBBQ B Invesco Nasdaq Biotechnology ETF 3.91
    MOHR B Mohr Growth ETF 3.37
    View all Chronic Condition ETFs...
    Compare ETFs
    Compare FLUD to MOHR Compare MEDX to MOHR Compare PPH to MOHR

        Chronic Condition Stocks Recent News

        Date Stock Title
        Jul 5 AZN AstraZeneca & Aptamer partner to bolster targeted siRNA therapies
        Jul 5 AZN AstraZeneca’s Tagrisso plus chemotherapy wins EU approval for NSCLC
        Jul 5 AZN AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
        Jul 5 AZN Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
        Jul 5 EHAB AREX Capital Expresses Disappointment in Enhabit’s Continued Excuses and Empty Promises
        Jul 5 AZN Investors in AstraZeneca (LON:AZN) have seen strong returns of 115% over the past five years
        Jul 5 AZN What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
        Jul 2 AZN AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use
        Jul 2 OPCH Option Care Health Insiders Placed Bullish Bets Worth US$3.22m
        Jul 2 HUMA While institutions own 20% of Humacyte, Inc. (NASDAQ:HUMA), individual investors are its largest shareholders with 50% ownership
        Jul 2 AZN EMA fast-tracks review of AstraZeneca’s sipavibart to stop Covid
        Jul 1 EHAB Enhabit Releases Investor Presentation Demonstrating Execution of Clear Growth Strategy and Path to Unlock Shareholder Value
        Jul 1 AZN AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment
        Jul 1 HUMA Humacyte stock rallies 19% on FDA RMAT designation
        Jul 1 HUMA Humacyte Acellular Tissue Engineered Vessel (ATEV™) Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for Patients with Advanced Peripheral Artery Disease (PAD)
        Jul 1 AZN AstraZeneca COVID prevention antibody gets EU fast-track review
        Jul 1 AZN Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
        Related Industries: Biotechnology Drug Manufacturers - Major Medical Care Medical Care Facilities Medical Devices
        Related Stock Lists: Disease Medicine Arthritis Chronic Pain Diabetes Disorders Drug Delivery Technology Health Care Health Sciences Hypertension Parkinson's Disease Respiratory Diseases Schizophrenia Acid Alzheimer's Disease Anemia Angina Antibodies Antipsychotic Asthma
        Chronic Condition

        Chronic conditions are long-term health conditions that last for more than three months and cannot be cured. Examples of chronic conditions include diabetes, asthma, heart disease, arthritis, and depression. These conditions require ongoing medical care and can have a significant impact on a person's quality of life.

        Browse All Tags